HTA Database - Search Results

Sort by Relevance

Search Results [15895 Hits] Selected Records [0 Hits] [Clear]

Year	Source	Title
2019	NIHR Public Health Research (PHR) programme	NAP SACC UK: a feasibility cluster randomised controlled trial in child care settings to increase physical activity and healthy eating in 2-4 year olds
2019	NIHR Health Technology Assessment programme	Behavioural Activation Therapy for Depression after Stroke (BEADS): a feasibility randomised controlled pilot trial of a psychological intervention for post-stroke depression
2019	NIHR Public Health Research (PHR) programme	Adapting a falls prevention exercise programme with and for older people with visual impairment: a feasibility study
2019	NIHR Public Health Research (PHR) programme	A multi-centre individual-randomised controlled trial of screening and brief alcohol intervention to prevent risky drinking in young people aged 14-15 in a high school setting (SIPS JR-HIGH)
2019	NIHR Health Services and Delivery Research programme	Investigating the contribution of physician associates (PAs) to secondary care in England: a mixed methods study
2019	NIHR Health Services and Delivery Research programme	Improving NHS quality using internet ratings and experiences (INQUIRE)
2019	NIHR Health Services and Delivery Research programme	Evaluation of specialist nursing support for carers of people with dementia
2019	NIHR Health Services and Delivery Research programme	Understanding and enhancing how hospital staff learn from and act on patient experience data
2019	NIHR Health Services and Delivery Research programme	A study of sense-making strategies and help-seeking behaviours associated with the use and provision of urgent care services
2019	NIHR Public Health Research (PHR) programme	How can interventions integrating health and academic education in schools help prevent substance misuse and violence, and reduce health inequalities among young people? Systematic review and evidence synthesis
2019	NIHR Health Services and Delivery Research programme	Evaluating the ten year impact of the Productive Ward at the clinical microsystem level in English acute trusts
2019	NIHR Public Health Research (PHR) programme	Mass media for public health messages
2019	NIHR Health Technology Assessment programme	Treatment of first-time traumatic anterior shoulder dislocation UK.TASH-D Study
2019	NIHR Health Services and Delivery Research programme	The changing general practitioner workforce: the development of policies and strategies aimed at retaining experienced GPs and those taking a career break in direct patient care (ReGROUP)
2019	NIHR Health Services and Delivery Research programme	PRESENT: Patient Reported Experience Survey Engineering of Natural Text: developing practical automated analysis and dashboard representations of cancer survey freetext answers
2019	NIHR Health Services and Delivery Research programme	Exploring the impact of patient experience data in acute NHS hospital trusts in England: using Actor-Network Theory to optimise organisational strategies and practices for improving patients' experiences of care
2019	NIHR Public Health Research (PHR) programme	Improving health, under community supervision, with the support of a Health Trainer: developing and evaluating a pilot randomised controlled trial
2019	NIHR Health Technology Assessment programme	Improving the mental health of children and young people with long term conditions: linked evidence syntheses
2019	NIHR Health Technology Assessment programme	Minimally invasive autopsy for fetuses and children based on a combination of post-mortem MRI and endoscopic autopsy examination; feasibility study
2019	NIHR Health Technology Assessment programme	Trial of Acute Femoral Fracture Fixation (TrAFFix). A feasibility study
2019	NIHR Health Services and Delivery Research programme	Innovation to enhance health in care homes: rapid evidence synthesis
2019	NIHR Health Technology Assessment programme	Balance Right in Multiple Sclerosis (BRiMS): a guided self-management programme to reduce falls and improve quality of life, balance and mobility in people with multiple sclerosis
2019	NIHR Health Services and Delivery Research programme	Innovation to enhance health in care homes: rapid evidence synthesis
2019	NIHR Health Technology Assessment programme	The Effectiveness and cost-effectiveness of Surgical Treatments for womEn with stRess urinary incontinence: an evidence synthesis (ESTER)
2019	NIHR Health Technology Assessment programme	Cabozantinib and vandatinib for treating advanced or metastatic medullary thyroid cancer (ID56)
2019	NIHR Health Technology Assessment programme	An evaluation of the feasibility of conducting a randomised clinical trial to evaluate the clinical and cost-effectiveness of a more permissive temperature threshold for antipyretic intervention in critically ill children with fever due to infection: the FEVER feasibility study
2019	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Gait speed as predictor of frailty]
2019	Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU)	[Scientific evidence and evidence gaps in social care regarding assessment routines and interventions for persons with substance abuse, and their families]
2019	Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU)	[Assessment and interventions in care and services for older adults - an evidence map]
2019	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Irreversible electroporation for the treatment of liver and pancreatic cancer]
2019	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	Diagnostic accuracy and clinical utility of PET/CT amyloid in mild cognitive impairment
2019	Adelaide Health Technology Assessment (AHTA)	Heritable Mutations associated with Familial Hypercholesterolaemia
2019	Belgian Health Care Knowledge Centre (KCE)	Bariatric surgery : an HTA report on the efficacy, safety and cost-effectiveness
2019	Belgian Health Care Knowledge Centre (KCE)	Cost-effectiveness analysis of HPV vaccination of boys in Belgium
2019	Belgian Health Care Knowledge Centre (KCE)	The use of statins in the primary prevention of cardiovascular disease: an online tool for shared-decision making
2019	Belgian Health Care Knowledge Centre (KCE)	Proton beam therapy in adults
2019	Belgian Health Care Knowledge Centre (KCE)	Statins for the primary prevention of cardiovascular events
2019	NIHR Health Services and Delivery Research programme	Developing a reporting guideline to improve meta-ethnography in health research: the eMERGe mixed-methods study
2019	NIHR Health Services and Delivery Research programme	Innovation to enhance health in care homes and evaluation of tools for measuring outcomes of care: rapid evidence synthesis
2019	NIHR Health Services and Delivery Research programme	Digital and online symptom checkers and assessment services for urgent care to inform a new digital platform: a systematic review
2019	NIHR Health Services and Delivery Research programme	Improving care for women and girls who have undergone female genital mutilation/cutting: qualitative systematic reviews
2019	NIHR Health Services and Delivery Research programme	Multicomponent hospital-led interventions to reduce hospital stay for older adults following elective surgery: a systematic review
2019	NIHR Health Technology Assessment programme	Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis
2019	NIHR Health Technology Assessment programme	Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic model
2019	NIHR Health Technology Assessment programme	Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis
2019	NIHR Health Technology Assessment programme	Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation
2019	NIHR Health Technology Assessment programme	Surgical treatments for women with stress urinary incontinence: the ESTER systematic review and economic evaluation
2019	NIHR Health Technology Assessment programme	Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis
2019	NIHR Horizon Scanning Centre (NIHR HSC)	An intervention to improve outcomes of falls in dementia: the DIFRID mixed-methods feasibility study
2019	NIHR Health Technology Assessment programme	Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation
2019	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Stereotactic neurosurgery frameless. The iSYS1® Robotic device]
2019	Andalusian Health Technology Assessment Area (AETSA)	PET usefulness in non-oncological indications
2019	Andalusian Health Technology Assessment Area (AETSA)	Clinical Utility of Procalcitonin–Guidance for initiation of antimicrobian treatment in patients admitted to the ICU
2019	NIHR Public Health Research (PHR) programme	Mass media to communicate public health messages in six health topic areas: a systematic review and other reviews of the evidence
2019	Finnish Coordinating Center for Health Technology Assessment (FinCCHTA)	[Surgical smoke during operations - the risks to personnel, and the protective measures needed]
2019	Swiss Federal Office of Public Health (FOPH)	Removal of osteosynthesis materials (e.g. screws, plates, nails and wires) used to treat bone fractures
2019	Swiss Federal Office of Public Health (FOPH)	Self-measurement of blood glucose in patients with non-insulin treated diabetes mellitus type 2
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Transcatheter aortic valve implantation (TAVI) in patients at intermediate surgical risk
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Natalizumab for the Treatment of Relapsing-Remitting Multiple Sclerosis
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Bioresorbable stents for the treatment of cardiovascular indications (coronary artery disease). EUnetHTA-Report
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Olaparib (Lynparza®) as first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Atezolizumab (Tecentriq®) with nab-paclitaxel (Abraxane®) for the treatment of advanced triple-negative breast cancer (aTNBC)
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	C-reactive protein point-of-care testing (CRP POCT) to guide antibiotic prescribing in primary care settings for acute respiratory tract infections. EUnetHTA-Report
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Evaluation methods for the benefit assessment of easily accessible, outpatient health centres for vulnerable groups - Target group focus: Homeless and non-insured persons
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Robot-assisted surgery in thoracic and visceral indications
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Darolutamide for the treatment of patients with nonmetastatic castration-resistant prostate cancer (CRPC)
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Annulus Fibrosus Repair after lumbar discectomy
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Single/two-step scaffold-based cartilage repair in the knee and ankle joint
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Radiofrequency denervation for lumbar and cervical facet joint pain – a systematic review
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Upper Airway Stimulation for Moderate-to-Severe Sleep Apnea. 1st Update 2019
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Osteochondral allograft transplantation for the knee (or other joints)
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Allograft for anterior and posterior cruciate ligament reconstruction
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Human dermal allograft for massive rotator cuff tears
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	177Lu-PSMA Therapy in Patients with Metastatic Castration-Resistant Prostate
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Custom-made or customisable 3D printed implants and cutting guides versus non- 3D printed standard implants and cutting guides for improving outcome in patients undergoing knee, maxillofacial, or cranial surgery
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Brentuximab vedotin (Adcetris®) in combination with chemotherapy for CD30-positive peripheral T-cell lymphoma (PTCLs)
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Irreversible electroporation for the treatment of liver and pancreatic cancer
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Screening and prevention programmes for children and adolescents from 6 to 14 years. Results from selected countries and recommendations from evidence-based guidelines
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Screening for Diabetes mellitus: guideline recommendations
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Public & philanthropic financial contribution to the development of new drugs: Methodology & 3 Case Studies
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	FoundationOne®CDx: genetic profiling of solid tumours
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Enzalutamide (Xtandi®) in addition to standard first-line therapy in men with metastatic hormone-sensitive prostate cancer (mHSPC)
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Sponsoring of Patient Initiatives in Austria 2018. Update of the Systematic Analyses 2014, 2015 and 2016
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Pharma: Disclosure of transfers of value in Austria 2018. Update of the systematic analysis 2015
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Pembrolizumab (Keytruda®) as first-line therapy for PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (NSCLC)
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Screening programs for children and adolescents from 6 to 18 years. Results on selected countries, Austrian screening programmes and recommendations from evidence-based guidelines
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Rehabilitation for children and adolescents in Austria: A systematic analysis of evaluation methodologies
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Cervical Carcinoma Prevention - Implementation of an HPV screening test for early detection of cervical cancer in Austria
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	POCT/ Point of Care Tests: D-Dimer and Troponin
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Minimum volume standards for quality assurance in day surgery: Fundamentals and Systematic Review
2019	Andalusian Health Technology Assessment Area (AETSA)	Genetic diseases in Spain. Map of genetic test available in the National Health System. Upgrade.
2019	Health Quality Ontario (HQO)	Intermittent Catheters for Chronic Urinary Retention: A Health Technology Assessment
2019	Health Quality Ontario (HQO)	Compression Stockings for the Prevention of Venous Leg Ulcer Recurrence: A Health Technology Assessment
2019	Health Quality Ontario (HQO)	Cervical Artificial Disc Replacement Versus Fusion for Cervical Degenerative Disc Disease: A Health Technology Assessment
2019	Technology Assessment at SickKids (TASK)	A microcosting and cost-consequence analysis of genomic testing strategies (including trios) in autism spectrum disorder: an update
2019	Technology Assessment at SickKids (TASK)	The economic evaluation of early intervention with anti-tumor necrosis factor-α treatments in pediatric Crohn's disease
2019	Technology Assessment at SickKids (TASK)	A cost-utility analysis of biosimilar infliximab compared to reference infliximab in adult switch patients with Crohn’s disease: a Canadian analysis
2019	The Federal Joint Committee (G-BA)	[Pharmaceutical Directive/Annex XII: Axicabtagene ciloleucel]
2019	Health Quality Ontario (HQO)	Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment
2019	Health Quality Ontario (HQO)	Perspectives of Pregnant People and Clinicians on Noninvasive Prenatal Testing: A Systematic Review and Qualitative Meta-synthesis